State Street Spdr S P Biotech Etf (XBI)

Nov 25, 2025

Apple, Taiwan Semiconductor Manufacturing And More On CNBC's 'Final Trades' - Benzinga

Nov 25, 2025

Nov 24, 2025

Best-Performing ETFs of Last Week: Healthcare Rules - sharewise.com

Nov 24, 2025

Nov 21, 2025

Why biotech and drug stocks are on the mend even though the rest of the market is hurting - MSN

Nov 21, 2025

Nov 21, 2025

ETFs Investing in Janux Therapeutics, Inc. Stocks - TradingView

Nov 21, 2025

Nov 20, 2025

3 Biotech Stocks Wall Street Analysts Predict Will More Than Double - Markets Financial Content

Nov 20, 2025

Nov 20, 2025

S&P 500: Health Care Stocks Come Alive — Nudging Tech Aside For Now - Investor's Business Daily

Nov 20, 2025

Nov 20, 2025

Biotech ETF (XBI) Hits New 52-Week High - MSN

Nov 20, 2025

Nov 19, 2025

Biotech Stock Gets Booted in Latest Fund Update - The Motley Fool

Nov 19, 2025

Nov 19, 2025

Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com

Nov 19, 2025

Nov 19, 2025

(11/19/25) PFE: The Winner in the Metsera Bidding War - moneyshow.com

Nov 19, 2025

Nov 18, 2025

Why biotech and drug stocks are rallying even though the rest of the market is hurting - MarketWatch

Nov 18, 2025

Nov 17, 2025

M&A Injects Life Into Biotech Trade - TheStreet Pro

Nov 17, 2025

Nov 16, 2025

XBI: Biotech Funding Condition Recovery Could Be Overdue (NYSEARCA:XBI) - Seeking Alpha

Nov 16, 2025

Nov 16, 2025

XBI: An Equal Weight ETF On Biotech That Amplifies Its Speculative Component - Seeking Alpha

Nov 16, 2025

Nov 14, 2025

Breakthrough bets on life sciences rebound with $430m fundraise - Private Equity Real Estate | PERE

Nov 14, 2025

Nov 14, 2025

This Biotech Stock Soared 100%. Merck Is Buying It. - Barron's

Nov 14, 2025

Nov 13, 2025

META_TITLE_SECTORS - Yahoo Finance

Nov 13, 2025

Nov 12, 2025

Two Biotech Stocks to Watch as Sector Bounces Back - TheStreet Pro

Nov 12, 2025

Nov 12, 2025

Should You Invest in the State Street SPDR S&P Semiconductor ETF (XSD)? - Yahoo Finance

Nov 12, 2025

Nov 11, 2025

Should You Invest in the State Street SPDR S&P Oil & Gas Exploration & Production ETF (XOP)? - Nasdaq

Nov 11, 2025

Nov 07, 2025

Is State Street SPDR S&P Retail ETF (XRT) a Strong ETF Right Now? - sharewise.com

Nov 07, 2025

Nov 06, 2025

Is State Street SPDR S&P Bank ETF (KBE) a Strong ETF Right Now? - Yahoo Finance

Nov 06, 2025

Nov 06, 2025

Should You Invest in the State Street SPDR S&P Retail ETF (XRT)? - Nasdaq

Nov 06, 2025

Nov 06, 2025

Is the Drought in Life-Sciences IPOs Over? Two Startups Will Test Demand - The Wall Street Journal

Nov 06, 2025

Nov 04, 2025

Experiments, Mergers, and Interest Rate Cuts: The Biotechnology Sector Ushers in a New Cycle - NAI500

Nov 04, 2025

Nov 03, 2025

SPDR S&P Biotech ETF declares quarterly distribution of $0.0267 - MSN

Nov 03, 2025

Nov 03, 2025

SPDR S&P Biotech ETF Options Spot-On: On November 3rd, 78,510 Contracts Were Traded, With 811.5K Open Interest - 富途牛牛

Nov 03, 2025

Nov 03, 2025

SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada

Nov 03, 2025

Nov 03, 2025

Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? - Benzinga

Nov 03, 2025

Nov 02, 2025

Biopharmaceutical stocks performed strongly against the market trend, bolstered by industry mergers and acquisitions as well as favorable policy developments. - 富途牛牛

Nov 02, 2025

Oct 31, 2025

It's a high-risk trade, but this biotech down 80% this year could be a buy - CNBC

Oct 31, 2025

Oct 30, 2025

Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin - Benzinga

Oct 30, 2025

Oct 30, 2025

Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView

Oct 30, 2025

Oct 27, 2025

Why Is Intellia Therapeutics Stock Sinking Monday?Intellia Therapeutics (NASDAQ:NTLA) - Benzinga

Oct 27, 2025

Oct 26, 2025

StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market - Genetic Engineering and Biotechnology News

Oct 26, 2025

Oct 24, 2025

Have Biotech Stocks Returned To Health After Years Of Sickness? - Investor's Business Daily

Oct 24, 2025

Oct 21, 2025

Analyst Says He’s Buying This Biotech ETF, Predicts ‘Multi-Year’ Breakout - Insider Monkey

Oct 21, 2025

Oct 20, 2025

Guarantor: JPMorgan Chase & Co. - StreetInsider

Oct 20, 2025

Oct 17, 2025

Biotech Is Finally Rallying. Why Mizuho’s Jared Holz Is Optimistic This Time. - Barron's

Oct 17, 2025

Oct 17, 2025

XBI, CRSP, INSM, IONS: Large Inflows Detected at ETF - Nasdaq

Oct 17, 2025

Oct 15, 2025

The Technical Signals Behind (XBI) That Institutions Follow - news.stocktradersdaily.com

Oct 15, 2025

Oct 15, 2025

SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Benzinga

Oct 15, 2025

Oct 14, 2025

(XBI) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Oct 14, 2025

Oct 14, 2025

(XBI) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Oct 14, 2025

Oct 14, 2025

Discipline and Rules-Based Execution in XBI Response - news.stocktradersdaily.com

Oct 14, 2025

Oct 14, 2025

XPH: Small-Cap Pharma Turns Higher, At Long Last (NYSEARCA:XPH) - Seeking Alpha

Oct 14, 2025

Oct 13, 2025

Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com

Oct 13, 2025

Oct 13, 2025

String of acquisitions fuels biotech optimism - Sherwood News

Oct 13, 2025

Oct 13, 2025

Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance

Oct 13, 2025

Oct 13, 2025

Truist Financial Corp Sells 5,213 Shares of SPDR S&P Biotech ETF $XBI - Defense World

Oct 13, 2025

Oct 13, 2025

Vontobel Holding Ltd. Sells 7,846 Shares of SPDR S&P Biotech ETF $XBI - Defense World

Oct 13, 2025